635 related articles for article (PubMed ID: 16541261)
21. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
Wang L; Goschnick MW; Coppel RL
Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
[TBL] [Abstract][Full Text] [Related]
22. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
[TBL] [Abstract][Full Text] [Related]
23. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
Chatterjee S; Wery M; Sharma P; Chauhan VS
Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of immunogenicity of an oral Salmonella vaccine expressing recombinant Plasmodium berghei merozoite surface protein-1.
Toebe CS; Clements JD; Cardenas L; Jennings GJ; Wiser MF
Am J Trop Med Hyg; 1997 Feb; 56(2):192-9. PubMed ID: 9080880
[TBL] [Abstract][Full Text] [Related]
25. Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes.
Burns JM; Adeeku EK; Dunn PD
Infect Immun; 1999 Feb; 67(2):675-80. PubMed ID: 9916076
[TBL] [Abstract][Full Text] [Related]
26. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
Reed RC; Louis-Wileman V; Cosmai EV; Fang S; Jue DL; Wohlhueter RM; Hunter RL; Lal AA
Vaccine; 1997 Apr; 15(5):482-8. PubMed ID: 9160515
[TBL] [Abstract][Full Text] [Related]
27. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
Lougovskoi AA; Okoyeh NJ; Chauhan VS
Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model.
Lopera-Mesa TM; Kushwaha A; Mohmmed A; Chauhan VS
Vaccine; 2008 Mar; 26(10):1335-43. PubMed ID: 18272263
[TBL] [Abstract][Full Text] [Related]
29. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.
Daly TM; Long CA
Infect Immun; 1993 Jun; 61(6):2462-7. PubMed ID: 8363656
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
[TBL] [Abstract][Full Text] [Related]
31. Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.
Yoshida S; Nagumo H; Yokomine T; Araki H; Suzuki A; Matsuoka H
PLoS One; 2010 Oct; 5(10):e13727. PubMed ID: 21060850
[TBL] [Abstract][Full Text] [Related]
32. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.
Rodrigues MM; Cordey AS; Arreaza G; Corradin G; Romero P; Maryanski JL; Nussenzweig RS; Zavala F
Int Immunol; 1991 Jun; 3(6):579-85. PubMed ID: 1716146
[TBL] [Abstract][Full Text] [Related]
33. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against ribosomal phosphoprotein P0 of Plasmodium falciparum protect mice against challenge with Plasmodium yoelii.
Chatterjee S; Singh S; Sohoni R; Singh NJ; Vaidya A; Long C; Sharma S
Infect Immun; 2000 Jul; 68(7):4312-8. PubMed ID: 10858250
[TBL] [Abstract][Full Text] [Related]
35. Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies.
Benjamin PA; Ling IT; Clottey G; Valero LM; Ogun SA; Fleck SL; Walliker D; Morgan WD; Birdsall B; Feeney J; Holder AA
Mol Biochem Parasitol; 1999 Nov; 104(2):147-56. PubMed ID: 10593171
[TBL] [Abstract][Full Text] [Related]
36. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
Jaijyan DK; Singh H; Singh AP
J Biol Chem; 2015 Aug; 290(32):19496-511. PubMed ID: 25960542
[TBL] [Abstract][Full Text] [Related]
37. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
Vanderberg JP; Khan ZM; Stewart MJ
J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
[TBL] [Abstract][Full Text] [Related]
38. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
[TBL] [Abstract][Full Text] [Related]
39. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.
Kedzierski L; Black CG; Goschnick MW; Stowers AW; Coppel RL
Infect Immun; 2002 Dec; 70(12):6606-13. PubMed ID: 12438332
[TBL] [Abstract][Full Text] [Related]
40. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
